Potti A - Search Results

1

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A. Acharya CR, et al. Among authors: potti a. JAMA. 2008 Apr 2;299(13):1574-87. doi: 10.1001/jama.299.13.1574. JAMA. 2008. PMID: 18387932 Retracted.

2

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, West M, Harpole DH Jr, Nevins JR. Potti A, et al. N Engl J Med. 2006 Aug 10;355(6):570-80. doi: 10.1056/NEJMoa060467. N Engl J Med. 2006. PMID: 16899777 Free article. Retracted.

3

Mining gene expression profiles: expression signatures as cancer phenotypes.

Nevins JR, Potti A. Nevins JR, et al. Among authors: potti a. Nat Rev Genet. 2007 Aug;8(8):601-9. doi: 10.1038/nrg2137. Epub 2007 Jul 3. Nat Rev Genet. 2007. PMID: 17607306 Review.

4

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.

Hsu DS, Balakumaran BS, Acharya CR, Vlahovic V, Walters KS, Garman K, Anders C, Riedel RF, Lancaster J, Harpole D, Dressman HK, Nevins JR, Febbo PG, Potti A. Hsu DS, et al. Among authors: potti a. J Clin Oncol. 2007 Oct 1;25(28):4350-7. doi: 10.1200/JCO.2007.11.0593. J Clin Oncol. 2007. PMID: 17906199 Retracted.

5

Genomic strategies for personalized cancer therapy.

Garman KS, Nevins JR, Potti A. Garman KS, et al. Among authors: potti a. Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R226-32. doi: 10.1093/hmg/ddm184. Hum Mol Genet. 2007. PMID: 17911165 Review.

6

Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.

Anguiano A, Potti A. Anguiano A, et al. Among authors: potti a. Expert Rev Mol Diagn. 2007 Nov;7(6):837-44. doi: 10.1586/14737159.7.6.837. Expert Rev Mol Diagn. 2007. PMID: 18020912 Review.

7

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, Cameron D, Bergh J, Nevins JR, Iggo RD. Bonnefoi H, et al. Among authors: potti a. Lancet Oncol. 2007 Dec;8(12):1071-1078. doi: 10.1016/S1470-2045(07)70345-5. Epub 2007 Nov 19. Lancet Oncol. 2007. PMID: 18024211 Retracted. Clinical Trial.

8

Age-specific differences in oncogenic pathway deregulation seen in human breast tumors.

Anders CK, Acharya CR, Hsu DS, Broadwater G, Garman K, Foekens JA, Zhang Y, Wang Y, Marcom K, Marks JR, Mukherjee S, Nevins JR, Blackwell KL, Potti A. Anders CK, et al. Among authors: potti a. PLoS One. 2008 Jan 2;3(1):e1373. doi: 10.1371/journal.pone.0001373. PLoS One. 2008. PMID: 18167534 Free PMC article.

9

Utilization of genomic signatures to direct use of primary chemotherapy.

Potti A, Nevins JR. Potti A, et al. Curr Opin Genet Dev. 2008 Feb;18(1):62-7. doi: 10.1016/j.gde.2008.01.018. Epub 2008 Mar 12. Curr Opin Genet Dev. 2008. PMID: 18339540 Review.

10

An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.

Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom KP, Olson J, Nevins JR, Potti A. Salter KH, et al. Among authors: potti a. PLoS One. 2008 Apr 2;3(4):e1908. doi: 10.1371/journal.pone.0001908. PLoS One. 2008. PMID: 18382681 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page